These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34411641)

  • 1. Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs.
    Šalamúnová P; Saloň I; Ruphuy G; Kroupová J; Balouch M; Hanuš J; Štěpánek F
    Eur J Pharm Biopharm; 2021 Nov; 168():15-25. PubMed ID: 34411641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation of poorly soluble drugs in yeast glucan particles by spray drying improves dispersion and dissolution properties.
    Ruphuy G; Saloň I; Tomas J; Šalamúnová P; Hanuš J; Štěpánek F
    Int J Pharm; 2020 Feb; 576():118990. PubMed ID: 31899318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of curcumin solid dispersion using HPMC.
    Yu JY; Kim JA; Joung HJ; Ko JA; Park HJ
    J Food Sci; 2020 Nov; 85(11):3866-3873. PubMed ID: 33067846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
    Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-stranded β-1,3-1,6-glucan as a carrier for improved dissolution and membrane permeation of poorly water-soluble compounds.
    Uchiyama H; Dowaki M; Kadota K; Arima H; Sugiyama K; Tozuka Y
    Carbohydr Polym; 2020 Nov; 247():116698. PubMed ID: 32829826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
    Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM; Lee PI
    Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug.
    My Tran KT; Vo TV; Lee BJ; Duan W; Ha-Lien Tran P; Truong-Dinh Tran T
    Curr Drug Deliv; 2018; 15(4):576-584. PubMed ID: 28595530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion.
    Bhardwaj V; Trasi NS; Zemlyanov DY; Taylor LS
    Int J Pharm; 2018 Apr; 540(1-2):106-119. PubMed ID: 29425762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
    Liang Q; Wang YR; Deng YY
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(15):3305-3311. PubMed ID: 31602887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A
    Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
    Stocker MW; Healy AM; Ferguson S
    Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-glucan and arabinogalactan-based xerogels for abuse-deterrent opioid formulations.
    Veverka M; Dubaj T; Veverková E; Šimon P; Husár Š; Tomanová K; Jorík V
    Eur J Pharm Sci; 2019 Mar; 129():132-139. PubMed ID: 30625367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.